Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 181.97B P/E 27.08 EPS this Y 6.20% Ern Qtrly Grth -91.00%
Income 6.95B Forward P/E 12.21 EPS next Y 7.80% 50D Avg Chg -5.00%
Sales 51.83B PEG 3.02 EPS past 5Y 5.36% 200D Avg Chg 1.00%
Dividend N/A Price/Book 3.09 EPS next 5Y 4.50% 52W High Chg -9.00%
Recommedations 2.20 Quick Ratio 0.95 Shares Outstanding 2.12B 52W Low Chg 16.00%
Insider Own 0.01% ROA 4.61% Shares Float 2.05B Beta -
Inst Own 8.63% ROE 10.93% Shares Shorted/Prior 5.32M/5.36M Price 85.85
Gross Margin 70.12% Profit Margin 13.42% Avg. Volume 2,025,475 Target Price 104.25
Oper. Margin 17.75% Earnings Date - Volume 3,852,437 Change -0.29%
About Novartis AG

Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company operates through two segments: Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and physicians. It also provides cardiovascular, ophthalmology, neuroscience, immunology, hematology, and solid tumor products. The Sandoz segment develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.

Novartis AG News
06:30 PM Patients with hidradenitis suppurativa experienced sustained efficacy and symptom improvement at one year when treated with Novartis Cosentyx®
02/02/23 Novartis Full Year 2022 Earnings: Misses Expectations
02/02/23 Novartis AG (NYSE:NVS) Q4 2022 Earnings Call Transcript
02/01/23 Over dinner in Davos, the CEOs of Novartis, Coca-Cola, and Grab shared what’s worrying them
02/01/23 Prime-Time Battles Drive GSK And Novo Nordisk In 2023; Novartis Preps Its Spinoff
02/01/23 Novartis (NVS) Q4 Earnings Top, Revenues Miss Estimates
02/01/23 Novartis Ag (NVS) Q4 2022 Earnings Call Transcript
02/01/23 Novartis Reports Mixed Bag Q4 Earnings, Forecasts Higher Sales, Profits Ahead Of Sandoz Spin-Off
02/01/23 Stocks to Watch in Europe: GSK, Novartis, Novo Nordisk, BBVA, Entain
02/01/23 UPDATE 3-Novartis says operating profit to grow again ahead of Sandoz spin-off
02/01/23 Novartis says operating profit to grow again ahead of Sandoz spin-off
02/01/23 Novartis continues to grow with further core margin expansion and achieves important innovation milestones
01/31/23 Incyte (INCY) to Report Q4 Earnings: What's in the Cards?
01/31/23 11 Most Undervalued Blue Chip Stocks To Buy According To Hedge Funds
01/31/23 Can Sanofi (SNY) Keep the Beat Streak Alive in Q4 Earnings?
01/30/23 Sandoz receives positive CHMP opinion for citrate-free high concentration formulation of adalimumab biosimilar
01/27/23 Could This Be Novartis' Next Blockbuster Medicine?
01/24/23 Novartis' (NVS) Unit to Acquire Astellas' Rights of Mycamine
01/24/23 Sandoz Acquires Antifungal Agent From Astellas, Reinforcing Hospital Offering
01/24/23 11 Most Undervalued Foreign Stocks To Buy According To Hedge Funds
NVS Chatroom

User Image BusinessInAudio Posted - 26 minutes from now

Does Palantir Have A Prime Opportunity To Disrupt The Healthcare Space now that their software is being used to make better data driven descisions around patient flows? $NVS https://audea.io/audea?id=p3gJYBkLAdJ

User Image STCKPRO Posted - 1 hour ago

$NVS NEW ARTICLE : Patients with hidradenitis suppurativa experienced sustained efficacy and symptom improvement at one year when treated with Novartis Cosentyx® https://www.stck.pro/news/NVS/41848690

User Image MarketBeat Posted - 2 hours ago

Novartis announces annual dividend of $3.4694. Payable on 3/20/2023. 2.6% Yield. www.marketbeat.com/stocks/NYSE/NVS/dividend/ $NVS

User Image ChartMill Posted - 13 hours ago

$SEDG, $JD and $NVS all in the Weinstein stage 1 setup phase according to our stock screener. https://www.chartmill.com/stock/stock-screener?sid=96&f=p_pg10,v1_50b500,atrpct_a_1,we1,wsl_a_30,exch_us&v=3&type=CANDLES&timeframe=WEEKLY&months=0.05&o1=2&o2=3&op2=30%252C255,255&width=1000&i1=81&utm_source=stocktwits&utm_medium=screener&utm_content=Stock_Screener:_Weinstein_Stage_1_Setups,&utm_campaign=social_tracking

User Image ChartMill Posted - 17 hours ago

An Altman-Z score of 3.57 indicates that $NVS is not in any danger for bankruptcy at the moment. https://www.chartmill.com/stock/quote/NVS/fundamental-analysis?key=7f17267b-a4a9-471f-b45a-43619d0d18cc&utm_source=stocktwits&utm_medium=FA&utm_content=NVS&utm_campaign=social_tracking

User Image rafunrafun Posted - 20 hours ago

$AMRN 🗣 "Vascepa, brought to you by Novartis" has a pretty nice ring to it. $NVS

User Image Littlenicky5280 Posted - 1 day ago

$NVS I’ve got some company stock releasing to me from novartis tomorrow.What’s with the 2$ swing and what’s going on. Please and thank you.(used to work there don’t anymore)

User Image ChartMill Posted - 1 day ago

$NVS and $PFE showing up in our best Dividend Stock selection. https://www.chartmill.com/stock/stock-screener?sid=288&f=p_pg10,v1_50b500,sl_dvd_7_X,sl_he_5_X,sl_pr_5_X&s=dvd&v=19&utm_source=stocktwits&utm_medium=screener&utm_content=Stock_Screener:_Best_Dividend_Stocks&utm_campaign=social_tracking

User Image ideatrader Posted - 1 day ago

$NVS

User Image Rheinzand Posted - 1 day ago

$LPTX $BGNE $NVS Humor of the day! 🤓 A priest, a rabbit and minister walk into a bar. A bartender asks the rabbit “What’ll ya have?” The rabbit says “I dunno, I am only here cos of autocorrect.”😁😎

User Image STCKPRO Posted - 1 day ago

$NVS NEW ARTICLE : Novartis (NYSE:NVS) Down on Sluggish Q4 Sales https://www.stck.pro/news/NVS/41773029

User Image ChartMill Posted - 1 day ago

$NVS has a very good Piotroski-F score of 8.00. This indicates great health and profitability. https://www.chartmill.com/stock/quote/NVS/fundamental-analysis?key=7f17267b-a4a9-471f-b45a-43619d0d18cc&utm_source=stocktwits&utm_medium=FA&utm_content=NVS&utm_campaign=social_tracking

User Image cctranscripts Posted - 1 day ago

BlackRock, Inc. just provided an update on share ownership of Novartis AG https://www.conferencecalltranscripts.org/summary/?id=11751660 $NVS

User Image VeeTrade Posted - 1 day ago

$LPTX Today on the full year earnings call $NVS CEO Vas Narasimhan had this to say about possible M&A " When it comes to finding fresh oncology assets to buy or license, Narasimhan said the company remains “active” in the space. “If we can find attractive assets within our core cancers—lung cancer, prostate cancer, the gastric cancers, etc.—those are certainly things we would actively look at,” he said on the call. But tempting assets in any disease area will still need to have a price tag of under $5 billion—a limit that Narasimhan reiterated on this morning’s call. “We look at the full range of M&A possibilities, but our focus is on sub-$5 billion assets where we believe we have the opportunity to generate strong returns and find the most value,” the CEO explained.

User Image ChartMill Posted - 2 days ago

$NVS all in the Weinstein stage 1 setup phase according to our stock screener. https://www.chartmill.com/stock/stock-screener?sid=96&f=p_pg10,v1_50b500,atrpct_a_1,we1,wsl_a_30,exch_us&v=3&type=CANDLES&timeframe=WEEKLY&months=0.05&o1=2&o2=3&op2=30%252C255,255&width=1000&i1=81&utm_source=stocktwits&utm_medium=screener&utm_content=Stock_Screener:_Weinstein_Stage_1_Setups,&utm_campaign=social_tracking

User Image Newsfilter Posted - 2 days ago

$NVS Form SC 13G/A (statement of acquisition of beneficial ownership by individuals) filed with the SEC https://newsfilter.io/a/476964eb3f6afacea787f14c5d20f94c

User Image STCKPRO Posted - 2 days ago

$NVS NEW ARTICLE : TG Therapeutics: Strategy After Briumvi Launch https://www.stck.pro/news/NVS/41742706

User Image TickerDD_com Posted - 2 days ago

From 1/30/2023, looking back across 22 Month-Ends for NVS, Percentage Change of Average Monthly Price had More Positives (64%) while Percentage Change of Average Monthly Volume had More Positives (95%) $NVS #NVS #NVSStock #TickerDD #NVSNews https://www.youtube.com/watch?v=S85cbdWWY6Y

User Image STCKPRO Posted - 2 days ago

$NVS NEW ARTICLE : Novartis: Underlying Performance Is Compelling https://www.stck.pro/news/NVS/41736953

User Image cctranscripts Posted - 2 days ago

Reading notes stated as to $NVS conference call transcript https://conferencecalltranscripts.com/summary/?id=493467&pr=true

User Image stockilluminati Posted - 2 days ago

$NVS https://www.stockilluminati.com/nvs/news.php - Novartis AG (NVS) Q4 2022 Earnings Call Transcript

User Image stockilluminati Posted - 2 days ago

$NVS https://www.stockilluminati.com/nvs/news.php - Novartis: Underlying Performance Is Compelling

User Image cctranscripts Posted - 2 days ago

Novartis AG just filed its Annual and transition report of foreign http://www.conferencecalltranscripts.org/include?location=http://www.sec.gov/Archives/edgar/data/1114448/000137036823000006/0001370368-23-000006-index.htm $NVS

User Image cctranscripts Posted - 2 days ago

Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human https://www.conferencecalltranscripts.org/summary/?id=11749027 $NVS

User Image ChartMill Posted - 2 days ago

$NVS showing up in our best Dividend Stock selection. https://www.chartmill.com/stock/stock-screener?sid=288&f=p_pg10,v1_50b500,sl_dvd_7_X,sl_he_5_X,sl_pr_5_X&s=dvd&v=19&utm_source=stocktwits&utm_medium=screener&utm_content=Stock_Screener:_Best_Dividend_Stocks&utm_campaign=social_tracking

User Image Quantisnow Posted - 2 days ago

$NVS Multiple insights just appeared: 1. 📜 SEC Form IRANNOTICE filed by Novartis AG https://quantisnow.com/i/3984554?utm_source=stocktwits 2. 📜 SEC Form 6-K filed by Novartis AG https://quantisnow.com/i/3984571?utm_source=stocktwits 3. 📜 SEC Form 6-K filed by Novartis AG https://quantisnow.com/i/3984584?utm_source=stocktwits #healthcare

User Image EarningsInsider Posted - 2 days ago

Novartis AG Files SEC Form 6-K $NVS https://www.marketbeat.com/stocks/NYSE/NVS/sec-filings/

User Image EarningsInsider Posted - 2 days ago

Novartis AG Files SEC Form 20-F $NVS https://www.marketbeat.com/stocks/NYSE/NVS/sec-filings/

User Image stockilluminati Posted - 2 days ago

$NVS https://www.stockilluminati.com/nvs/news.php - Novartis AG 2022 Q4 - Results - Earnings Call Presentation

User Image Newsfilter Posted - 2 days ago

$NVS Form 6-K (report of foreign issuer [rules 13a-16 and 15d-16]) filed with the SEC https://newsfilter.io/a/d8bdb0a1eccfc4c5939876c2f4f67411

Analyst Ratings
Wolfe Research Peer Perform May 9, 22
Exane BNP Paribas Neutral Dec 6, 21
Bryan Garnier Neutral Dec 3, 21
Deutsche Bank Sell Sep 20, 21
Argus Research Hold Mar 10, 21
Cowen & Co. Market Perform Feb 1, 21
Deutsche Bank Buy Jan 15, 21
Morgan Stanley Overweight Sep 1, 20
Guggenheim Securities Neutral Feb 25, 20